Birdwatch Archive

Birdwatch Note

2024-03-23 00:57:54 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING

Repeated doses of mRNA vaccines for COVID-19 result in increased proportions of anti-spike antibodies of the IgG4 subclass https://www.science.org/doi/10.1126/sciimmunol.adg7327 Increased IgG4 synthesis due to repeated mRNA vaccination with high antigen concentrations may promote cancer growth https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10222767/#:~:text=Increased%20IgG4%20synthesis%20due%20to,autoimmune%20myocarditis%20in%20susceptible%20individuals.

Written by 27606C709209F7F3219A32743FFE5D0B254B7DE171A2113654DCA36892DB6BEF
Participant Details

Original Tweet

Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1771274695783875037

Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.

All Information

  • ID - 1771340559904653778
  • noteId - 1771340559904653778
  • participantId -
  • noteAuthorParticipantId - 27606C709209F7F3219A32743FFE5D0B254B7DE171A2113654DCA36892DB6BEF Participant Details
  • createdAtMillis - 1711155474055
  • tweetId - 1771274695783875037
  • classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
  • believable -
  • harmful -
  • validationDifficulty -
  • misleadingOther - 0
  • misleadingFactualError - 0
  • misleadingManipulatedMedia - 0
  • misleadingOutdatedInformation - 0
  • misleadingMissingImportantContext - 1
  • misleadingUnverifiedClaimAsFact - 0
  • misleadingSatire - 0
  • notMisleadingOther - 0
  • notMisleadingFactuallyCorrect - 0
  • notMisleadingOutdatedButNotWhenWritten - 0
  • notMisleadingClearlySatire - 0
  • notMisleadingPersonalOpinion - 0
  • trustworthySources - 1
  • summary
    • Repeated doses of mRNA vaccines for COVID-19 result in increased proportions of anti-spike antibodies of the IgG4 subclass https://www.science.org/doi/10.1126/sciimmunol.adg7327 Increased IgG4 synthesis due to repeated mRNA vaccination with high antigen concentrations may promote cancer growth https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10222767/#:~:text=Increased%20IgG4%20synthesis%20due%20to,autoimmune%20myocarditis%20in%20susceptible%20individuals.

Note Status History

createdAt timestampMillisOfFirstNonNMRStatus firstNonNMRStatus timestampMillisOfCurrentStatus currentStatus timestampMillisOfLatestNonNMRStatus mostRecentNonNMRStatus participantId
2024-03-23 00:57:54 UTC
(1711155474055)
2024-03-23 23:56:35 UTC
(1711238195594)
CURRENTLY_RATED_NOT_HELPFUL 2024-03-24 01:35:51 UTC
(1711244151884)
CURRENTLY_RATED_NOT_HELPFUL 2024-03-23 23:56:35 UTC
(1711238195594)
CURRENTLY_RATED_NOT_HELPFUL

Note Ratings

rated at rated by
2024-03-22 21:44:39 -0500 Rating Details
2024-03-22 21:06:22 -0500 Rating Details
2024-03-23 10:20:47 -0500 Rating Details
2024-03-23 02:23:33 -0500 Rating Details
2024-03-23 00:00:23 -0500 Rating Details
2024-03-22 23:58:22 -0500 Rating Details
2024-03-22 23:34:41 -0500 Rating Details
2024-03-24 06:14:28 -0500 Rating Details
2024-03-23 13:00:29 -0500 Rating Details
2024-03-23 11:45:48 -0500 Rating Details
2024-03-23 07:43:25 -0500 Rating Details
2024-03-23 07:21:05 -0500 Rating Details
2024-03-23 05:44:53 -0500 Rating Details
2024-03-23 04:14:31 -0500 Rating Details
2024-03-23 03:30:26 -0500 Rating Details
2024-03-23 01:46:44 -0500 Rating Details
2024-03-23 01:45:35 -0500 Rating Details
2024-03-23 00:59:35 -0500 Rating Details
2024-03-22 20:41:07 -0500 Rating Details
2024-03-22 20:39:51 -0500 Rating Details
2024-03-22 20:10:53 -0500 Rating Details
2024-03-23 14:52:10 -0500 Rating Details
2024-03-23 12:39:28 -0500 Rating Details
2024-03-23 12:28:01 -0500 Rating Details
2024-03-23 08:00:21 -0500 Rating Details
2024-03-23 05:31:23 -0500 Rating Details
2024-03-23 02:38:43 -0500 Rating Details
2024-03-23 00:51:07 -0500 Rating Details
2024-03-22 23:38:16 -0500 Rating Details
2024-03-22 22:53:16 -0500 Rating Details
2024-03-22 22:34:23 -0500 Rating Details
2024-03-22 22:20:51 -0500 Rating Details
2024-03-22 20:53:27 -0500 Rating Details
2024-03-22 20:19:37 -0500 Rating Details